Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma
Abstract
Enzymatic debridement is a therapeutic strategy used clinically to remove necrotic tissue from wounds. Some of the enzymes utilized for debridement have been tested against bacterial pathogens, but the effectiveness of these agents in dispersing clinically relevant biofilms has not been fully characterized. Here, we developed an in vitro Staphylococcus aureus biofilm model that mimics wound-like conditions and employed this model to investigate the antibiofilm activity of four enzymatic compounds. Human plasma at concentrations of 0%–50% was supplemented into growth media and used to evaluate biofilm biomass accumulation over 24 hours and 48 hours in one methicillin-sensitive and five methicillin-resistant strains of S. aureus. Supplementation of media with 10% human plasma resulted in the most robust biofilms in all six strains. The enzymes α-amylase, bromelain, lysostaphin, and papain were then tested against S. aureus biofilms cultured in 10% human plasma. Quantification of biofilms after 2 hours and 24 hours of treatment using the crystal violet assay revealed that lysostaphin decreased biomass by up to 76%, whereas α-amylase, bromelain, and papain reduced biomass by up to 97%, 98%, and 98%, respectively. Scanning electron microscopy confirmed that the dispersal agents detached the biofilm exopolysaccharide matrix and bacteria from the growth surface. Lysostaphinmore »
- Authors:
-
- Joint Base San Antonio-Fort Sam Houston, TX (United States). Naval Medical Research Unit San Antonio. Maxillofacial Injury and Disease Dept.
- Joint Base San Antonio-Fort Sam Houston, TX (United States). Naval Medical Research Unit San Antonio. Maxillofacial Injury and Disease Dept.; Naval Medical Research Center, Silver Spring, MD (United States). Wound Infections Dept.
- Publication Date:
- Research Org.:
- Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC)
- OSTI Identifier:
- 1627994
- Grant/Contract Number:
- SC0014664
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Infection and drug resistance
- Additional Journal Information:
- Journal Volume: 9; Journal ID: ISSN 1178-6973
- Publisher:
- Dove Press
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; Infectious Diseases; Pharmacology & Pharmacy; MRSA; α-amylase; bromelain; lysostaphin; papain
Citation Formats
Millenbaugh, Nancy, Watters, Chase, Burton, Tarea, and Kirui, Dickson. Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma. United States: N. p., 2016.
Web. doi:10.2147/idr.s103101.
Millenbaugh, Nancy, Watters, Chase, Burton, Tarea, & Kirui, Dickson. Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma. United States. https://doi.org/10.2147/idr.s103101
Millenbaugh, Nancy, Watters, Chase, Burton, Tarea, and Kirui, Dickson. Wed .
"Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma". United States. https://doi.org/10.2147/idr.s103101. https://www.osti.gov/servlets/purl/1627994.
@article{osti_1627994,
title = {Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma},
author = {Millenbaugh, Nancy and Watters, Chase and Burton, Tarea and Kirui, Dickson},
abstractNote = {Enzymatic debridement is a therapeutic strategy used clinically to remove necrotic tissue from wounds. Some of the enzymes utilized for debridement have been tested against bacterial pathogens, but the effectiveness of these agents in dispersing clinically relevant biofilms has not been fully characterized. Here, we developed an in vitro Staphylococcus aureus biofilm model that mimics wound-like conditions and employed this model to investigate the antibiofilm activity of four enzymatic compounds. Human plasma at concentrations of 0%–50% was supplemented into growth media and used to evaluate biofilm biomass accumulation over 24 hours and 48 hours in one methicillin-sensitive and five methicillin-resistant strains of S. aureus. Supplementation of media with 10% human plasma resulted in the most robust biofilms in all six strains. The enzymes α-amylase, bromelain, lysostaphin, and papain were then tested against S. aureus biofilms cultured in 10% human plasma. Quantification of biofilms after 2 hours and 24 hours of treatment using the crystal violet assay revealed that lysostaphin decreased biomass by up to 76%, whereas α-amylase, bromelain, and papain reduced biomass by up to 97%, 98%, and 98%, respectively. Scanning electron microscopy confirmed that the dispersal agents detached the biofilm exopolysaccharide matrix and bacteria from the growth surface. Lysostaphin caused less visible dispersal of the biofilms, but unlike the other enzymes, induced morphological changes indicative of bacterial cell damage. Overall, our results indicate that use of enzymes may be an effective means of eradicating biofilms and a promising strategy to improve treatment of multidrug-resistant bacterial infections.},
doi = {10.2147/idr.s103101},
journal = {Infection and drug resistance},
number = ,
volume = 9,
place = {United States},
year = {Wed Apr 27 00:00:00 EDT 2016},
month = {Wed Apr 27 00:00:00 EDT 2016}
}
Works referenced in this record:
Antimicrobial enzymes: An emerging strategy to fight microbes and microbial biofilms
journal, January 2013
- Thallinger, Barbara; Prasetyo, Endry N.; Nyanhongo, Gibson S.
- Biotechnology Journal, Vol. 8, Issue 1
Topical agents and wound healing
journal, January 1994
- Bolton, Laura; Fattu, Ann-Jeanette
- Clinics in Dermatology, Vol. 12, Issue 1
The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms
journal, June 2009
- Di Poto, Antonella; Sbarra, Maria S.; Provenza, Giulio
- Biomaterials, Vol. 30, Issue 18
D-Enantiomeric Peptides that Eradicate Wild-Type and Multidrug-Resistant Biofilms and Protect against Lethal Pseudomonas aeruginosa Infections
journal, February 2015
- de la Fuente-Núñez, César; Reffuveille, Fany; Mansour, Sarah C.
- Chemistry & Biology, Vol. 22, Issue 2
An improved medium for growing Staphylococcus aureus biofilm
journal, August 2012
- Chen, Ping; Abercrombie, Johnathan J.; Jeffrey, Nicole R.
- Journal of Microbiological Methods, Vol. 90, Issue 2
Activated ClpP kills persisters and eradicates a chronic biofilm infection
journal, November 2013
- Conlon, B. P.; Nakayasu, E. S.; Fleck, L. E.
- Nature, Vol. 503, Issue 7476
Activity of disinfectants against multispecies biofilms formed byStaphylococcus aureus,Candida albicansandPseudomonas aeruginosa
journal, February 2014
- Kart, Didem; Tavernier, Sarah; Van Acker, Heleen
- Biofouling, Vol. 30, Issue 3
Comparison of hexamethyldisilazane and critical point drying treatments for SEM analysis of anaerobic biofilms and granular sludge
journal, September 2003
- Araujo, J. C.
- Journal of Electron Microscopy, Vol. 52, Issue 4
Lysostaphin Disrupts
Staphylococcus aureus
and
Staphylococcus epidermidis
Biofilms on Artificial Surfaces
journal, November 2003
- Wu, Julie A.; Kusuma, Caroline; Mond, James J.
- Antimicrobial Agents and Chemotherapy, Vol. 47, Issue 11
Comparison of Four Methods for Determining Lysostaphin Susceptibility of Various Strains of
Staphylococcus aureus
journal, August 2005
- Kusuma, Caroline M.; Kokai-Kun, John F.
- Antimicrobial Agents and Chemotherapy, Vol. 49, Issue 8
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
journal, April 2002
- Donlan, R. M.; Costerton, J. W.
- Clinical Microbiology Reviews, Vol. 15, Issue 2
Synergistic Interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an
In Vitro
Wound Model
journal, November 2014
- DeLeon, Stephanie; Clinton, Allie; Fowler, Haley
- Infection and Immunity, Vol. 82, Issue 11
Staphylococcus epidermidis Esp Degrades Specific Proteins Associated with Staphylococcus aureus Biofilm Formation and Host-Pathogen Interaction
journal, April 2013
- Sugimoto, Shinya; Iwamoto, Takeo; Takada, Koji
- Journal of Bacteriology, Vol. 195, Issue 8
Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms
journal, January 2009
- Pettit, Robin K.; Weber, Christine A.; Pettit, George R.
- Annals of Clinical Microbiology and Antimicrobials, Vol. 8, Issue 1
Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro
journal, July 2014
- Cardile, Anthony P.; Sanchez, Carlos J.; Samberg, Meghan E.
- BMC Research Notes, Vol. 7, Issue 1
The Use of Commercially Available Alpha-Amylase Compounds to Inhibit and Remove Staphylococcus aureus Biofilms
journal, June 2011
- Bradford, Craigen
- The Open Microbiology Journal, Vol. 5, Issue 1
Influence of papain in biofilm formed by methicillin-resistant Staphylococcus epidermidis and methicillin-resistant Staphylococcus haemolyticus isolates
dataset, January 2022
- Oliveira, Hanna Lara da Cruz Dinéas de; Fleming, Maria Emília Castro Kling; Silva, Patrícia Vollu
- SciELO journals
Works referencing / citing this record:
Effect of Subtilisin-like Proteinase of Bacillus pumilus 3–19 on Pseudomonas aeruginosa Biofilms
journal, February 2019
- Kabanov, Daniil; Khabipova, Nailia; Valeeva, Lia
- BioNanoScience, Vol. 9, Issue 2
Análise da “1a Recomendação Brasileira para o Gerenciamento do Biofilme em Feridas Crônicas e Complexas”
journal, October 2019
- Viviana Serna González, Carol; Thum, Magali; de Oliveira Ramalho, Aline
- ESTIMA, Brazilian Journal of Enterostomal Therapy
Analysis of “1st Brazilian Recommendation for Biofilm Management in Chronic and Complex Wounds”
journal, October 2019
- Viviana Serna González, Carol; Thum, Magali; de Oliveira Ramalho, Aline
- ESTIMA, Brazilian Journal of Enterostomal Therapy
Glycoside Hydrolases Degrade Polymicrobial Bacterial Biofilms in Wounds
journal, November 2016
- Fleming, Derek; Chahin, Laura; Rumbaugh, Kendra
- Antimicrobial Agents and Chemotherapy, Vol. 61, Issue 2
Enzymatic Inactivation of Pathogenic and Nonpathogenic Bacteria in Biofilms in Combination with Chlorine
journal, March 2019
- Kim, Min-Jeong; Lim, Eun Seob; Kim, Joo-Sung
- Journal of Food Protection, Vol. 82, Issue 4
Secretome of Intestinal Bacilli: A Natural Guard against Pathologies
journal, September 2017
- Ilinskaya, Olga N.; Ulyanova, Vera V.; Yarullina, Dina R.
- Frontiers in Microbiology, Vol. 8
Ultrasound‐mediated therapies for the treatment of biofilms in chronic wounds: a review of present knowledge
journal, May 2020
- LuTheryn, Gareth; Glynne‐Jones, Peter; Webb, Jeremy S.
- Microbial Biotechnology, Vol. 13, Issue 3
Matrix metalloprotease-1 inhibits and disrupts Enterococcus faecalis biofilms
journal, January 2019
- Kumar, Lokender; Cox, Christopher R.; Sarkar, Susanta K.
- PLOS ONE, Vol. 14, Issue 1
Secretome of Intestinal Bacilli: A Natural Guard against Pathologies
journal, September 2017
- Ilinskaya, Olga N.; Ulyanova, Vera V.; Yarullina, Dina R.
- Frontiers in Microbiology, Vol. 8
Approaches to Dispersing Medical Biofilms
journal, April 2017
- Fleming, Derek; Rumbaugh, Kendra
- Microorganisms, Vol. 5, Issue 2
The Synergy of Ciprofloxacin and Carvedilol against Staphylococcus aureus–Prospects of a New Treatment Strategy?
journal, November 2019
- Zawadzka, Katarzyna; Nowak, Marta; Piwoński, Ireneusz
- Molecules, Vol. 24, Issue 22
Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections
journal, April 2018
- Blanchette, Krystle A.; Wenke, Joseph C.
- Journal of Bone and Joint Infection, Vol. 3, Issue 2